HODNOCENÍStudy Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020Pfizer Inc (“Pfizer”) wishes to sponsor a clinical study entitled (“Study”) to be conducted by Principal Investigator at Institution under the Pfizer protocol identified above (“Protocol”). Study duration: beginning of the study is planned for July 2017, first visit of the last subject is planned to 29 March 2019. Pfizer has delegated